Compare ARK Genomic Revolution ETF (ARKG) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Robinhood Markets, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Robinhood Markets, Inc. trades at $111.1 (market cap $100.52B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Robinhood Markets, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | HOOD | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $152.46 |
52-Week Low | $23.09 | $65.16 |
Market Cap | — | $100.52B |
Enterprise Value | — | $101.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Robinhood (HOOD) trades at $111.97, down 2.73% on the day, with a bullish technical outlook supported by moving averages and strong support at $109. The company shows robust fundamentals with 2025 revenue of $4.47 billion and net income of $1.88 billion, though valuation ratios remain elevated with a P/E of 54.35. Recent news highlights growth initiatives including a Trump Accounts program and AI integration in fintech.
Outlook remains positive with 73% analyst buy ratings and a $112.44 consensus target, but risks include high valuation sensitivity and competitive pressures. Earnings momentum is key, with Q2 2026 results expected to drive near-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
